Assessment of Hand Grip and Pinch Strengths in Children with Autism Spectrum Disorders: A Cross-Sectional Study
Abstract
Background/objective: Children with autism spectrum disorders (ASD) are recognized to experience challenges with muscle function. However, there is a lack of knowledge about muscle and hand grip strength in autism. Therefore, the study aims to assess the handgrip and pinch strength of ASD and typical children. Material and method: This study enrolled 45 participants of both sexes, 27 males and 18 females, aged 6–12 years old; 24 (13 females and 11 males) were typically developing children and 21 (5 females and 16 males) had ASD. The outcome measures were hand grip and pinch strength, with the handheld dynamometer assessing handgrip strength and the hydraulic pinch gauge evaluating pinch grip. The hydraulic pinch gauge measured the pinch strengths of the key, tripod, and pulp grips. Both groups were assessed on both their dominant and non-dominant sides. Result: A comparison of the ASD group with the control group revealed that children with ASD exhibited lower values of the hand grip, key pinch, tripod pinch, and pulp pinch strengths for both hands (p < 0.05). Conclusions: The hand and pinch strengths of ASD children are lower than those of typically developing children. Therefore, the evaluation process for children with ASD should include hand and pinch strengths as a standard component. Furthermore, the rehabilitation program for ASD should prioritize enhancing hand strength.
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 45 participants or records.
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.